TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD3+ cell repopulation in NOD/SCID mice

PLAŠILOVÁ, M., ŽIVNÝ, J., JELÍNEK, J., NEUWIRTOVÁ, R., ČERMÁK, J., NEČAS, E., ANDĚRA, L., STOPKA, T. TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD3+ cell repopulation in NOD/SCID mice. Blood. 2001, 98(11), 3043. ISSN 0006-4971. E-ISSN 1528-0020.